Flu shot may curb respiratory infections in people with heart failure
(HealthDay)—Flu and pneumonia vaccines may reduce heart failure patients' risk of dangerous respiratory infections, a new review suggests.
Feb 2, 2017
0
1
(HealthDay)—Flu and pneumonia vaccines may reduce heart failure patients' risk of dangerous respiratory infections, a new review suggests.
Feb 2, 2017
0
1
Two-thirds of California prisoners who were offered a COVID-19 vaccine accepted at least one dose, according to a new study by researchers at the Stanford University School of Medicine.
May 12, 2021
0
2
COVID-19 vaccine shortages are leading some to question whether the United States would be better off simply trying to give a single dose to as many people as possible.
Feb 5, 2021
0
3
A new Boston University School of Medicine (BUSM) study has found that low-income and minority parents may be more receptive to vaccinating their daughters against Human Papillomavirus (HPV), while white, middle-class parents ...
May 14, 2013
0
0
Fewer people are dying from cancer in the United States, but a government report published Monday warned that a lack of preventative measures could stem a steady decline in mortality rates.
Jan 7, 2013
0
0
The pharmaceutical industry on Tuesday proposed a system to allow for more equitable access to vaccines and treatments in future pandemics, saying it was willing to set aside doses to distribute to lower-income countries.
Jul 19, 2022
0
2
(HealthDay)—Despite increases since 2008, human papillomavirus (HPV) vaccination rates are suboptimal within ages 9 to 12 years, according to a study published online May 3 in Pediatrics.
May 4, 2021
0
6
Maintaining social distancing policies as vaccines are being rolled out may prevent the evolution of vaccine-resistant strains of SARS-CoV-2, suggests a mathematical biology study published in Nature Human Behaviour.
Feb 25, 2022
0
46
More than 450 people are dying of COVID-19 in the U.S. each day as of late August 2022.
Aug 31, 2022
0
5
Long-term follow-up of a phase II clinical trial showed encouraging survival in some patients with stage 3B/4 non-small cell lung cancer treated with belagenpumatucel-L, a therapeutic vaccine. The findings were presented ...
Apr 4, 2012
0
1